Medical network - July 11, for a long time, because of a shortage of children decongestion, hospital can only replace the children's drugs and dosage forms with adult drugs and dosage forms, the industry and even medicine can only be circulated children "drug use by snapping, dose by guess" evaluation. At present, many so-called children drug on the market, most of the time just the decrement of adult medicine edition, hidden trouble to our bring to children's health. On July 10, Beijing business newspaper reporter learns from within, national health development planning commission, has made it clear that this year have children research and development and speed up the approval of the drug as a key task for the layout, the next few years children medicine shortage is expected to be resolved.
According to the white paper in 2016 children's medication safety report showed that more than 6000 pharmaceutical companies in our country, only a dozen professional manufacturers of children's drugs. Due to the improper use, our country each year about 30000 children deafness.
Wu zhen, deputy chief of the state food administration of drug safety, according to the analysis of children's medicine is shortage of capacity shortage, structural shortage and price.
Affiliated to the capital university of medical sciences, the temple of heaven, Beijing hospital authority always pharmacists frank zhao, director of the cqi further explained that at present, our country children less clinical medication, the approval document number of domestic has about 180000 varieties, more than 3000 children's drugs, accounted for less than 2%, only involving more than 400 varieties. This relatively in 220 million children, the prevalence of 12% is far from enough.
Experts said that in these phenomena are behind the policy does not form a complete set, children's drugs marketization degree and low profit. "For examination and approval of our country's at present for children's drugs listed in the agency, policy management in the department of public health, clinical use in medical institutions, reserve management in the ministry departments, each responsible for a while, regulations, standards don't match, not unified, have a disconnect." The experts say, and children, not just a smaller version of the adult, the organ is not mature, the clinical characteristic and the process mechanism of drug absorption, compliance, need special formula, preparation and taste, make the drug research and development production process, the cost is high, more leading companies reluctant to engage in the r&d, production and sale of children decongestion.
, national food drug safety administration says it will focus around ability and structural shortages, take measures to encourage this kind of product registration, declaration, and the shortage of this kind of medicine to speed up the review.
Yi-xin zeng said deputy director of the national health development planning commission, the state development planning commission and other six department has issued several opinions to protect children's drugs, made the list two batches of encourage research and development. Especially in the national major projects in development of new, have put the children's medicine research and development and speed up the approval as a key task for layout. "Drugs for children, children according to the different weight will have the right dose, dosage form, in the form of oral liquid; and should be suitable for children's taste, let children willing to drink it. This is the focus of 'much starker choices-and graver consequences-in, ministry of science and technology, ministry of finance, food and drug administration, who planning commission to speed up the special research and development and approval process for Chinese children's drugs. Estimates in a few years children medicine shortage phenomenon will be effectively solved." |
